Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

In Deusa Cast #46, experts like Jaime Ozi analyze the barriers preventing Brazil from advancing in cannabis regulation and highlight the impact of the lack of research, medical education, and access.

Agronomist engineer Ana Paula Porfírio, head of the Social Participation and Diversity Advisory of the Ministry of Agriculture and Livestock (MAPA), and researcher Beatriz Emydio, from Embrapa, will participate in the panel “Cannabis in Brazil: Challenges and Perspectives of Post-Regulation Cultivation”

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Nearly 80% of middle-aged women turn to cannabis or CBD to relieve menopausal symptoms like sleep and mood, reveals Menopause research

Discover what cannabis ruderalis is, its main characteristics, uses, effects, and why it arouses the interest of growers and researchers

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

The event brings together experts, companies, and authorities to discuss regulatory advances, research, and innovation in cannabis-based therapies, connecting the entire public and private sector

With applications ranging from the pharmaceutical industry to construction, the sector is being structured with machinery, research, and investments, and is expected to grow even before the definitive regulation of cultivation in Brazil; the consultant discussed the topic during an interview at Andav 2025

Survey reveals that states where recreational marijuana is legalized have seen accelerated growth in residential property values, according to research.

Meeting at PUC-SP discusses cannabis associativism, social justice, and the right to health, bringing together activists, patients, and researchers in a conversation circle this Tuesday.

The Brazilian Association of Cannabinoid Industry (BRcann) forum brought together sector representatives and Anvisa to discuss regulatory updates, research, information, and market

Patients with peripheral diabetic neuropathy experience at least 50% pain relief, according to a study conducted at the General Clinical Research Center of the University of California Medical Center (UCSD).

The analysis, published by the Journal of the American Medical Association, examined federal data from the Youth Risk Behavior Survey between 1993 and 2019, in 10 U.S. states, comparing both medical and adult use.

The Federal Court understood that there could be no contradiction between law No. 23,737 on narcotics, which criminalizes users, and law No. 27,350, on research for medicinal and scientific use of the Cannabis plant and its derivatives

More than a third of Parkinson's patients are using natural remedies, such as cannabis, coffee, and saffron, to manage their symptoms, according to a study published in the Journal of Parkinson’s. The research also revealed that many of these patients do not discuss the use of natural products with their doctors.

Agreement between regulatory agency and veterinary institute evaluates the use of cannabidiol as an alternative to antibiotics in poultry farming

Study shows that cannabis extract can reduce chronic lower back pain and improve the quality of life of patients

Brazilian study proposes a new model on the C15:0 lipid, highlighting its triphasic action in regulating inflammation, metabolism, and longevity

Study shows that the combination of cannabis and propolis extracts can enhance antibacterial and anti-inflammatory effects, pointing to new possibilities for natural therapies